CLINICAL_TRIALS
trial_result
· 2021-06-18
Clinical Trial Update: A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder [Phase 3]
Summary
Phase 3 trial of duloxetine (LY248686) in Japanese children and adolescents with depressive disorder terminado; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shionogi | Conditions: Depressive Disorder | Phase 3 | Status: TERMINATED | Results posted: 2021-06-18